Friday 6 November 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024.

Revenue: −31.8%
EPS: −123.8%
Free cash flow: −268.5%
Total debt: +153.3%

Quarter to September 2026, against a year earlier

306.43 7.43 +2.48%

Follow LGND

Alert me

Market cap: $6.0B
P/E: 118×
Fwd P/E: 88.3×
Dividend yield: —
F-score: 6/9
Altman Z: 5.45
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	5	4
ROE Full definition →		13.47%	17.13%	21.96%	5.38%
ROA Full definition →		9.95%	12.60%	12.58%	2.77%
ROIC Full definition →		3.62%	9.06%	8.19%	0.91%
Return on Tangible Assets Full definition →		15.66%	18.62%	13.98%	10.48%
Average Days of Receivables Full definition →		83.12	72.87	87.84	119.67
Free Cash Flow per Share Full definition →		3.15	6.77	7.15	4.04
Free Cash Flow Full definition →		60.91	134.59	143.37	80.58
Capital Expenditures Full definition →		11.56	11.09	11.65	(10.45)
Other line items
Cash ROIC Full definition →		2.74%	6.02%	4.14%	3.18%
Accounts Receivable Turnover Full definition →		5.18	5.62	4.75	3.59
Accounts Payable Turnover Full definition →		3.44	2.44	1.48	0.56
Inventory Turnover Full definition →		1.25	0.93	1.03	0.92
Average Days of Payables Full definition →		81.23	148.10	258.50	1,196.50
Days of Inventory on Hand Full definition →		228.95	373.24	282.08	436.59
Tax Rate Full definition →		(0.22)	(0.17)	(0.17)	(0.02)
Research and Development Expense of Revenue Full definition →		30.28%	12.11%	14.23%	9.10%
Selling, General and Administrative Expense of Revenue Full definition →		34.48%	34.42%	35.60%	58.15%
Share Based Compensation of Revenue Full definition →		17.48%	18.07%	18.33%	22.34%
Interest Coverage Full definition →		8.70	16.91	15.30	2.94
Operating CF/Net income Full definition →		0.40	0.80	0.67	1.77
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.38	0.38	0.40	(0.31)
Revenue per Share Full definition →		13.86	13.80	14.48	12.72
Operating CF per Share Full definition →		2.55	6.21	6.57	4.56
Capex per Share Full definition →		0.60	0.56	0.58	(0.52)
Capex to Sales Full definition →		(0.04)	(0.04)	(0.04)	0.04

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly